Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections.
about
Determinants of relapse periodicity in Plasmodium vivax malariaThe potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW IndiaPrimaquine for preventing relapses in people with Plasmodium vivax malariaEpidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEuropPrimaquine radical cure of Plasmodium vivax: a critical review of the literatureEpidemiology of Plasmodium vivax Malaria in IndiaA randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of plasmodium vivax in Northwest Frontier Province, PakistanResistance to therapies for infection by Plasmodium vivaxGeographical variation in Plasmodium vivax relapseTemporal genetic changes in Plasmodium vivax apical membrane antigen 1 over 19 years of transmission in southern Mexico.Antirelapse Efficacy of Various Primaquine Regimens for Plasmodium vivaxGenotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata.Multiple-clone activation of hypnozoites is the leading cause of relapse in Plasmodium vivax infectionRandomized, open-label trial of primaquine against vivax malaria relapse in IndonesiaAssessment of safety of the major antimalarial drugs.RADICAL CURE OF VIVAX MALARIA : 5 OR 14 DAYSProspective Study of Plasmodium vivax Malaria Recurrence after Radical Treatment with a Chloroquine-Primaquine Standard Regimen in Turbo, ColombiaManagement of relapsing Plasmodium vivax malariaTherapeutic Assessment of Primaquine for Radical Cure of Plasmodium vivax Malaria at Primary and Tertiary Care Centres in Southwestern India.Malaria and National Vector Borne Disease Control Programme.Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India.Chloroquine-Primaquine versus Chloroquine Alone to Treat Vivax Malaria in Afghanistan: An Open Randomized Superiority Trial.Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
P2860
Q17485692-99553BB9-9D63-4D39-BAAA-66874BFC5D0CQ21562247-079F6C77-B738-4B77-BA4D-EAD8A7F48478Q24246197-62CCF5FB-0F73-43CD-BBB4-D60AB3AB5FA7Q24804103-72C3145B-400A-4AF0-88F4-04AFDAFA8FC4Q27027939-E35EB9D1-01EC-49A2-882A-559D3ED18352Q28355353-D73E9399-69F6-4156-A6B8-43081F1D6FFAQ33358051-582B4EB5-C4CB-42CE-844A-8DE012F20C23Q33481576-FD856BB2-AC6C-47D7-A805-23955149612DQ33613545-1307AE34-1C79-4CE9-97E7-2E6E08328993Q33630458-EB764C36-209A-48A5-930D-9B48EF31FF28Q34252526-D98989C0-A1D6-4F06-9EB9-717F95CBC5DBQ34341592-535B289D-1EEF-4367-A721-95786CB65DC3Q34490613-226A9083-B2D1-40BF-8E84-AE5324D58D13Q36666980-FF53A410-6D09-482D-95E8-981CAE14D9F5Q36945007-784B94C7-109D-442C-887B-A0EDC9F798C2Q37048123-DD44CE0E-F678-49F7-8818-6CC6C160D0A4Q37120100-1D3ACE8A-69BD-41B9-A329-646907F9A085Q37290599-E47D70DE-B39A-4E8B-A8BC-E013003B348EQ37606572-2EA1434C-76BA-4DCA-95BA-697DE1875372Q44160113-FB70145B-B055-4466-A709-7D5B7F012ADCQ44983136-0C07288D-793E-4BDC-B548-EA7DCF47CFD9Q48016667-ABEBC560-B81C-4361-A864-71D2E61A85B5Q53691594-3B2CEC30-1DAF-48F7-8B5E-2BA2DDA64FFB
P2860
Efficacies of 5- and 14-day primaquine regimens in the prevention of relapses in Plasmodium vivax infections.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@ast
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@en
type
label
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@ast
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@en
prefLabel
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@ast
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@en
P2093
P356
P1476
Efficacies of 5- and 14-day pr ...... n Plasmodium vivax infections.
@en
P2093
P304
P356
10.1080/00034989957790
P577
1999-12-01T00:00:00Z